申请人:Boehringer Mannheim GmbH
公开号:US04443477A1
公开(公告)日:1984-04-17
The invention provides sulphonamides of the formula ##STR1## wherein R is a hydrogen atom or a lower alkyl radical; R.sub.1 is alkyl, aryl, aralkyl or aralkenyl, the aryl moiety of which in each case can be optionally substituted one or more times by hydroxyl, halogen, trifluoromethyl, lower alkyl or alkoxy or by acyl, carboxy or alkoxycarbonyl; n is 1, 2 or 3; and W is a valence bond or a divalent aliphatic hydrocarbon linkage and the physiologically acceptable salts, esters and amides of such compound. These compounds have excellent pharmacological lipid depressing activity and inhibit thrombocyte aggregation.
本发明提供了以下式子的磺胺类化合物:##STR1## 其中,R为氢原子或较低的烷基基团;R.sub.1为烷基,芳基,芳基烷基或芳基烯基,其中芳基基团可以选择地被羟基,卤素,三氟甲基,较低的烷基或烷氧基,或酰基,羧基或烷氧羰基取代一次或多次;n为1、2或3;W为一个价键或二价的脂肪族碳链,并且这些化合物的生理学上可接受的盐,酯和酰胺。这些化合物具有优异的药理学降脂活性和抑制血小板聚集的作用。